BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/22/2021 12:47:36 PM | Browse: 15 | Download: 18
Publication Name World Journal of Clinical Oncology
Manuscript ID 59742
Country/Territory Spain
Received
2020-09-27 17:27
Peer-Review Started
2020-09-27 17:27
To Make the First Decision
Return for Revision
2021-01-07 06:20
Revised
2021-01-07 15:24
Second Decision
2021-01-21 03:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-01-26 18:31
Articles in Press
2021-01-26 18:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-01-29 23:27
Typeset the Manuscript
2021-02-01 05:32
Publish the Manuscript Online
2021-02-22 12:47
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Metastatic hormone-sensitive prostate cancer: How should it be treated?
Manuscript Source Invited Manuscript
All Author List Fernando López-Campos, Carmen González-San Segundo, Antonio José Conde-Moreno and Felipe Couñago
ORCID
Author(s) ORCID Number
Fernando López-Campos http://orcid.org/0000-0002-4077-0507
Carmen González-San Segundo http://orcid.org/0000-0002-5489-5327
Antonio José Conde-Moreno http://orcid.org/0000-0003-1024-0924
Felipe Couñago http://orcid.org/0000-0001-7233-0234
Funding Agency and Grant Number
Corresponding Author Felipe Couñago, MD, PhD, Professor, Department of Radiation Oncology, Hospital Universitario Quirón Salud Madrid, Hospital La Luz, Universidad Europea de Madrid (UEM), Calle Diego de Velázquez, 1, 28223 Pozuelo de Alarcón, Madrid 28223, Spain. fcounago@gmail.com
Key Words Metastatic hormone-sensitive prostate cancer; Androgen-receptor signaling inhibitors; Abiraterone acetate; Enzalutamide; Apalutamide; Docetaxel
Core Tip Due to advances in the treatment of metastatic hormone-sensitive prostate cancer in recent years, multiple options are now available. The emergence of androgen receptor inhibitors provides patients with an alternative to chemotherapy. Given the increasingly important role of these novel treatments, a comprehensive review of the available data is needed. In addition, there are several unresolved questions and controversies surrounding these treatments, which can only be resolved by in-depth analysis and consensus among the specialists who treat these patients.
Publish Date 2021-02-22 12:47
Citation López-Campos F, González-San Segundo C, Conde-Moreno AJ, Couñago F. Metastatic hormone-sensitive prostate cancer: How should it be treated? World J Clin Oncol 2021; 12(2): 43-49
Url https://www.wjgnet.com/2218-4333/full/v12/i2/43.htm
DOI https://dx.doi.org/10.5306/wjco.v12.i2.43
Full Article (PDF) WJCO-12-43.pdf
Full Article (Word) WJCO-12-43.docx
Manuscript File 59742-Review-FilipodiaCL.doc
Answering Reviewers 59742-Answering reviewers.pdf
Audio Core Tip 59742-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 59742-Conflict-of-interest statement.pdf
Copyright License Agreement 59742-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 59742-Language certificate.pdf
Peer-review Report 59742-Peer-review(s).pdf
Scientific Misconduct Check 59742-Bing-Wang JL-1.jpg
Scientific Misconduct Check 59742-Scientific misconduct check.pdf
Scientific Editor Work List 59742-Scientific editor work list.pdf